Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas

Graeme Hodgson, Jeffrey H. Hager, Stas Volik, Sujatmi Hariono, Meredith Wernick, Dan Moore, Donna Albertson, Daniel Pinkel, Colin Collins, Douglas Hanahan, Joe W. Gray

Research output: Contribution to journalArticle

Abstract

Carcinomas that develop in the pancreatic islets of transgenic mice expressing the SV40 T-antigens (Tag) under transcriptional control of the rat insulin II promoter (RIP) progress through well-characterized stages that are similar to aspects of human tumor progression, including hyperplastic growth, increased angiogenesis and reduced apoptosis. The latter two stages have been associated with recurrent loss of heterozygosity (LOH) and reduced genome copy number on chromosomes 9 (LOH9) and 16 (LOH16), aberrations which we believe contribute to these phenotypes. Earlier analyses localized LOH9 to approximately 3 Mb and LOH16 to approximately 30 Mb (both syntenic with human 3q21-q25) but were limited by low throughput and a lack of informative polymorphic markers. Here we show that comparative genomic hybridization to DNA microarrays (array CGH) overcomes these limitations by allowing efficient, genome-wide analyses of relative genome copy number. The CGH arrays used in these experiments carried BACs distributed at 2-20-MB intervals across the mouse genome and at higher density in regions of interest. Using array CGH, we further narrowed the loci for LOH9 and LOH16 and defined new or previously unappreciated recurrent regions of copy-number decrease on chromosomes 6, 8 and 14 (syntenic with human chromosomes 12p11-p13, 16q24.3 and 13q11-q32, respectively) and regions of copy-number increase on chromosomes 2 and 4 (syntenic to human chromosomes 20q13.2 and 1p32-p36, respectively). Our analyses of human genome sequences syntenic to these regions suggest that CYP24, PFDN4, STMN1, CDKN1B, PPP2R3 and FSTL1 are candidate oncogenes or tumor-suppressor genes. We also show that irradiation and genetic background influence the spectrum of aberrations present in these tumors.

Original languageEnglish (US)
Pages (from-to)459-464
Number of pages6
JournalNature Genetics
Volume29
Issue number4
DOIs
StatePublished - 2001

Fingerprint

Genome
Carcinoma
Human Chromosomes
Oligonucleotide Array Sequence Analysis
Polyomavirus Transforming Antigens
Chromosomes, Human, Pair 16
Chromosomes, Human, Pair 14
Chromosomes, Human, Pair 8
Chromosomes, Human, Pair 9
Chromosomes, Human, Pair 4
Chromosomes, Human, Pair 6
Comparative Genomic Hybridization
Chromosomes, Human, Pair 2
Loss of Heterozygosity
Human Genome
Tumor Suppressor Genes
Islets of Langerhans
Oncogenes
Transgenic Mice
Neoplasms

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Hodgson, G., Hager, J. H., Volik, S., Hariono, S., Wernick, M., Moore, D., ... Gray, J. W. (2001). Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nature Genetics, 29(4), 459-464. https://doi.org/10.1038/ng771

Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. / Hodgson, Graeme; Hager, Jeffrey H.; Volik, Stas; Hariono, Sujatmi; Wernick, Meredith; Moore, Dan; Albertson, Donna; Pinkel, Daniel; Collins, Colin; Hanahan, Douglas; Gray, Joe W.

In: Nature Genetics, Vol. 29, No. 4, 2001, p. 459-464.

Research output: Contribution to journalArticle

Hodgson, G, Hager, JH, Volik, S, Hariono, S, Wernick, M, Moore, D, Albertson, D, Pinkel, D, Collins, C, Hanahan, D & Gray, JW 2001, 'Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas', Nature Genetics, vol. 29, no. 4, pp. 459-464. https://doi.org/10.1038/ng771
Hodgson G, Hager JH, Volik S, Hariono S, Wernick M, Moore D et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nature Genetics. 2001;29(4):459-464. https://doi.org/10.1038/ng771
Hodgson, Graeme ; Hager, Jeffrey H. ; Volik, Stas ; Hariono, Sujatmi ; Wernick, Meredith ; Moore, Dan ; Albertson, Donna ; Pinkel, Daniel ; Collins, Colin ; Hanahan, Douglas ; Gray, Joe W. / Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. In: Nature Genetics. 2001 ; Vol. 29, No. 4. pp. 459-464.
@article{48c8ae68b47d4d9abcb933b2c9b6402e,
title = "Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas",
abstract = "Carcinomas that develop in the pancreatic islets of transgenic mice expressing the SV40 T-antigens (Tag) under transcriptional control of the rat insulin II promoter (RIP) progress through well-characterized stages that are similar to aspects of human tumor progression, including hyperplastic growth, increased angiogenesis and reduced apoptosis. The latter two stages have been associated with recurrent loss of heterozygosity (LOH) and reduced genome copy number on chromosomes 9 (LOH9) and 16 (LOH16), aberrations which we believe contribute to these phenotypes. Earlier analyses localized LOH9 to approximately 3 Mb and LOH16 to approximately 30 Mb (both syntenic with human 3q21-q25) but were limited by low throughput and a lack of informative polymorphic markers. Here we show that comparative genomic hybridization to DNA microarrays (array CGH) overcomes these limitations by allowing efficient, genome-wide analyses of relative genome copy number. The CGH arrays used in these experiments carried BACs distributed at 2-20-MB intervals across the mouse genome and at higher density in regions of interest. Using array CGH, we further narrowed the loci for LOH9 and LOH16 and defined new or previously unappreciated recurrent regions of copy-number decrease on chromosomes 6, 8 and 14 (syntenic with human chromosomes 12p11-p13, 16q24.3 and 13q11-q32, respectively) and regions of copy-number increase on chromosomes 2 and 4 (syntenic to human chromosomes 20q13.2 and 1p32-p36, respectively). Our analyses of human genome sequences syntenic to these regions suggest that CYP24, PFDN4, STMN1, CDKN1B, PPP2R3 and FSTL1 are candidate oncogenes or tumor-suppressor genes. We also show that irradiation and genetic background influence the spectrum of aberrations present in these tumors.",
author = "Graeme Hodgson and Hager, {Jeffrey H.} and Stas Volik and Sujatmi Hariono and Meredith Wernick and Dan Moore and Donna Albertson and Daniel Pinkel and Colin Collins and Douglas Hanahan and Gray, {Joe W.}",
year = "2001",
doi = "10.1038/ng771",
language = "English (US)",
volume = "29",
pages = "459--464",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas

AU - Hodgson, Graeme

AU - Hager, Jeffrey H.

AU - Volik, Stas

AU - Hariono, Sujatmi

AU - Wernick, Meredith

AU - Moore, Dan

AU - Albertson, Donna

AU - Pinkel, Daniel

AU - Collins, Colin

AU - Hanahan, Douglas

AU - Gray, Joe W.

PY - 2001

Y1 - 2001

N2 - Carcinomas that develop in the pancreatic islets of transgenic mice expressing the SV40 T-antigens (Tag) under transcriptional control of the rat insulin II promoter (RIP) progress through well-characterized stages that are similar to aspects of human tumor progression, including hyperplastic growth, increased angiogenesis and reduced apoptosis. The latter two stages have been associated with recurrent loss of heterozygosity (LOH) and reduced genome copy number on chromosomes 9 (LOH9) and 16 (LOH16), aberrations which we believe contribute to these phenotypes. Earlier analyses localized LOH9 to approximately 3 Mb and LOH16 to approximately 30 Mb (both syntenic with human 3q21-q25) but were limited by low throughput and a lack of informative polymorphic markers. Here we show that comparative genomic hybridization to DNA microarrays (array CGH) overcomes these limitations by allowing efficient, genome-wide analyses of relative genome copy number. The CGH arrays used in these experiments carried BACs distributed at 2-20-MB intervals across the mouse genome and at higher density in regions of interest. Using array CGH, we further narrowed the loci for LOH9 and LOH16 and defined new or previously unappreciated recurrent regions of copy-number decrease on chromosomes 6, 8 and 14 (syntenic with human chromosomes 12p11-p13, 16q24.3 and 13q11-q32, respectively) and regions of copy-number increase on chromosomes 2 and 4 (syntenic to human chromosomes 20q13.2 and 1p32-p36, respectively). Our analyses of human genome sequences syntenic to these regions suggest that CYP24, PFDN4, STMN1, CDKN1B, PPP2R3 and FSTL1 are candidate oncogenes or tumor-suppressor genes. We also show that irradiation and genetic background influence the spectrum of aberrations present in these tumors.

AB - Carcinomas that develop in the pancreatic islets of transgenic mice expressing the SV40 T-antigens (Tag) under transcriptional control of the rat insulin II promoter (RIP) progress through well-characterized stages that are similar to aspects of human tumor progression, including hyperplastic growth, increased angiogenesis and reduced apoptosis. The latter two stages have been associated with recurrent loss of heterozygosity (LOH) and reduced genome copy number on chromosomes 9 (LOH9) and 16 (LOH16), aberrations which we believe contribute to these phenotypes. Earlier analyses localized LOH9 to approximately 3 Mb and LOH16 to approximately 30 Mb (both syntenic with human 3q21-q25) but were limited by low throughput and a lack of informative polymorphic markers. Here we show that comparative genomic hybridization to DNA microarrays (array CGH) overcomes these limitations by allowing efficient, genome-wide analyses of relative genome copy number. The CGH arrays used in these experiments carried BACs distributed at 2-20-MB intervals across the mouse genome and at higher density in regions of interest. Using array CGH, we further narrowed the loci for LOH9 and LOH16 and defined new or previously unappreciated recurrent regions of copy-number decrease on chromosomes 6, 8 and 14 (syntenic with human chromosomes 12p11-p13, 16q24.3 and 13q11-q32, respectively) and regions of copy-number increase on chromosomes 2 and 4 (syntenic to human chromosomes 20q13.2 and 1p32-p36, respectively). Our analyses of human genome sequences syntenic to these regions suggest that CYP24, PFDN4, STMN1, CDKN1B, PPP2R3 and FSTL1 are candidate oncogenes or tumor-suppressor genes. We also show that irradiation and genetic background influence the spectrum of aberrations present in these tumors.

UR - http://www.scopus.com/inward/record.url?scp=18344392245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18344392245&partnerID=8YFLogxK

U2 - 10.1038/ng771

DO - 10.1038/ng771

M3 - Article

VL - 29

SP - 459

EP - 464

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 4

ER -